Influenza

Showing NaN - NaN of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)

Not yet recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1083
  • +3 more
  • Anniston, Alabama
  • +172 more
Oct 18, 2023

SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)

Recruiting
  • SARS-CoV-2
  • Influenza
  • Fluarix
  • +8 more
  • Chandler, Arizona
  • +68 more
Apr 24, 2023

Influenza Trial in Worldwide (Baloxavir Marboxil, Placebo)

Recruiting
  • Influenza
  • Baloxavir Marboxil
  • Placebo
  • Birmingham, Alabama
  • +290 more
Jan 20, 2023

SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

Active, not recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1073
  • +3 more
  • Hollywood, Florida
  • +13 more
Oct 5, 2022

Defining Impact of Initial Influenza Exposure on Immunity in

Recruiting
  • Influenza
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Jun 23, 2022

    Influenza Trial in United States (FluBlok®, Placebo)

    Completed
    • Influenza
    • FluBlok®
    • Placebo
    • Beverly Hills, California
    • +23 more
    Mar 24, 2022

    Influenza, Human Trial in United States (Investigational aIIV4c, IIV4c type 1, aIIV4)

    Completed
    • Influenza
    • Human
    • Investigational aIIV4c
    • +3 more
    • Mobile, Alabama
    • +20 more
    Mar 15, 2022

    Influenza Trial in Worldwide (Liquid CAIV-T)

    Completed
    • Influenza
    • Liquid CAIV-T
    • Hoover, Alabama
    • +160 more
    Sep 10, 2021

    Influenza Trial in United States (Influenza A/Bethesda/MM2/H1N1 Challenge)

    Completed
    • Influenza
    • Influenza A/Bethesda/MM2/H1N1 Challenge
    • Baltimore, Maryland
    • +3 more
    Apr 1, 2021

    Asthma in Children, Vaccine Adverse Reaction, Vaccine Reaction Trial in Durham, Cincinnati, Nashville (Live Attenuated Influenza

    Completed
    • Asthma in Children
    • +5 more
    • Live Attenuated Influenza Vaccine (LAIV)
    • Inactivated Influenza Vaccine (IIV)
    • Durham, North Carolina
    • +2 more
    Feb 25, 2021

    Influenza, Vaccine Trial in Durham, Cincinnati (cH8/1N1 LAIV, AS03-adjuvanted cH5/1N1 IIV, cH5/1N1 IIV)

    Completed
    • Influenza
    • Vaccine
    • cH8/1N1 LAIV
    • +5 more
    • Durham, North Carolina
    • +1 more
    Feb 1, 2021

    Avian Influenza, Influenza, Influenza Immunisation Trial in United States (drug, biological, other)

    Completed
    • Avian Influenza
    • +2 more
    • Birmingham, Alabama
    • +3 more
    Jul 16, 2020

    Influenza, Influenza Immunisation Trial in Iowa City, Cincinnati, Houston (Influenza Multimeric-001 Vaccine, Placebo,

    Completed
    • Influenza
    • Influenza Immunisation
    • Influenza Multimeric-001 Vaccine
    • +2 more
    • Iowa City, Iowa
    • +2 more
    Jun 2, 2020

    Avian Influenza, Influenza Trial in United States (AS03, MF59 adjuvant, Monovalent Influenza A/H5N8 vaccine)

    Completed
    • Avian Influenza
    • Influenza
    • Iowa City, Iowa
    • +3 more
    Oct 22, 2019

    Influenza Trial in United States (Seasonal Influenza DNA vaccine, TIV)

    Completed
    • Influenza
    • Seasonal Influenza DNA vaccine
    • TIV
    • Atlanta, Georgia
    • +4 more
    Dec 4, 2018

    Influenza Trial in Worldwide (Oseltamivir)

    Completed
    • Influenza
    • Palo Alto, California
    • +49 more
    Oct 15, 2018

    Influenza Trial in Worldwide (Fluarix, Fluzone)

    Completed
    • Influenza
    • Fluarix
    • Fluzone
    • Birmingham, Alabama
    • +68 more
    Jul 2, 2018

    Influenza Trial in Worldwide (40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate, Placebo)

    Completed
    • Influenza
    • 40 mg Laninamivir Octanoate
    • +2 more
    • Scottsboro, Alabama
    • +220 more
    May 29, 2018

    Influenza Trial in United States (CSL Limited Influenza Virus Vaccine (Afluria®), US Licensed Influenza Virus Vaccine

    Completed
    • Influenza
    • CSL Limited Influenza Virus Vaccine (Afluria®)
    • US Licensed Influenza Virus Vaccine (Fluzone®)
    • Mountain Home, Arkansas
    • +12 more
    Apr 25, 2018

    Influenza Trial in United States (CSL's 2009 H1N1 Influenza Vaccine (CSL425), Placebo)

    Completed
    • Influenza
    • CSL's 2009 H1N1 Influenza Vaccine (CSL425)
    • Placebo
    • Chandler, Arizona
    • +12 more
    Apr 25, 2018

    Influenza Trial in United States (Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203)

    Completed
    • Influenza
    • Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203
    • Atlanta, Georgia
    • +7 more
    Jul 3, 2017

    Influenza Trial in United States (CSL's Influenza Virus Vaccine (Afluria), Influenza Virus Vaccine (Fluzone))

    Completed
    • Influenza
    • CSL's Influenza Virus Vaccine (Afluria)
    • Influenza Virus Vaccine (Fluzone)
    • Chandler, Arizona
    • +22 more
    Apr 16, 2017

    Influenza Trial in Worldwide (Fluarix, adjuvanted influenza vaccine)

    Completed
    • Influenza
    • Fluarix
    • adjuvanted influenza vaccine
    • Clearwater, Florida
    • +29 more
    Apr 20, 2017

    Influenza Trial in United States (Influenza)

    Completed
    • Influenza
    • Influenza
    • Clearwater, Florida
    • +14 more
    Jan 16, 2017